These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma. Benhammou JN, Aby ES, Shirvanian G, Manansala K, Hussain SK, Tong MJ. Sci Rep; 2020 Jun 18; 10(1):9902. PubMed ID: 32555268 [Abstract] [Full Text] [Related]
5. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel. Benhammou JN, Leng M, Shah SC, Cholankeril G, Dong TS, Patel AA, Tong MJ. JAMA Netw Open; 2023 Dec 01; 6(12):e2346380. PubMed ID: 38048128 [Abstract] [Full Text] [Related]
6. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study. Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. PLoS One; 2017 Dec 01; 12(10):e0186715. PubMed ID: 29077714 [Abstract] [Full Text] [Related]
10. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. Cabibbo G, Petta S, Barbara M, Attardo S, Bucci L, Farinati F, Giannini EG, Negrini G, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Virdone R, Marra F, Mega A, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Colecchia A, Persico M, Craxì A, Trevisani F, Cammà C, Italian Liver Cancer (ITA.LI.CA) group. J Hepatol; 2017 Jul 01; 67(1):65-71. PubMed ID: 28192185 [Abstract] [Full Text] [Related]
11. Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity. Pinheiro PS, Jones PD, Medina H, Cranford HM, Koru-Sengul T, Bungum T, Wong R, Kobetz EN, McGlynn KA. Clin Gastroenterol Hepatol; 2024 Mar 01; 22(3):562-571.e8. PubMed ID: 37678486 [Abstract] [Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.). Paik JM, Eberly KE, Kabbara K, Harring M, Younossi Y, Henry L, Verma M, Younossi ZM. Ann Hepatol; 2023 Jul 01; 28(4):101108. PubMed ID: 37088421 [Abstract] [Full Text] [Related]
17. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Ahn SY, Kim SB, Song IH. Can J Gastroenterol Hepatol; 2020 Jul 01; 2020():4873875. PubMed ID: 32566546 [Abstract] [Full Text] [Related]
19. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years. Idilman R, Aydogan M, Oruncu MB, Kartal A, Elhan AH, Ellik Z, Gumussoy M, Er R, Ozercan M, Duman S, Toruner M, Cinar K, Soykan I, Beyler AR, Ozkan H. Dig Dis; 2021 Jul 01; 39(4):358-365. PubMed ID: 33142287 [Abstract] [Full Text] [Related]